Literature DB >> 29095278

The additional benefit of weighted subjective global assessment (SGA) for the predictability of mortality in incident peritoneal dialysis patients: A prospective study.

Taeyoung Yun1, Ye Eun Ko, Seung-Jung Kim, Duk-Hee Kang, Kyu Bok Choi, Hyung Jung Oh, Dong-Ryeol Ryu.   

Abstract

Although subjective global assessment (SGA) is a widely used tool for nutritional investigation, the scores are dependent on the inspectors' subjective opinions, and there are only few studies that directly assessed the usefulness of SGA and modified SGA in incident peritoneal dialysis (PD) patients. A total of 365 incident PD patients between 2009 and 2015 were enrolled and measured with SGA and calculated using serum albumin and total iron binding capacity (TIBC) levels for weighted SGA. Cox analyses were performed to delineate the association between SGA or weighted SGA and all-cause mortality, and a receiver-operating characteristic was conducted to reveal the additional benefit of weighted SGA on predicting adverse clinical outcomes. The Kaplan-Meier curve showed that the cumulative survival rate in patients with "Good nutrition" (G1) was significantly higher compared to those with "Mild to severe malnutrition" (G2). G2 was significantly associated with an increase in the mortality even after adjusting for several covariates compared with G1. Moreover, a 1-unit increase in weighted SGA was also significantly correlated with mortality after adjustment of the same covariates, while G2 was not significantly associated with an increase in the mortality among young-aged (under 65 years) groups. Meanwhile, a 1-unit increase in weighted SGA was significantly related to an increase in mortality in all the subgroup analyses. Furthermore, the AUCs of weighted SGAs in all groups were significantly increased compared with those of SGA alone. In conclusions, the evaluation of nutritional status based on SGA in incident PD patients might be useful for predicting mortality. However, weighted SGA with serum albumin and TIBC can provide additional predictive power for mortality compared with SGA alone in incident PD patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29095278      PMCID: PMC5682797          DOI: 10.1097/MD.0000000000008421

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  6 in total

1.  Comparison of Content and Psychometric Properties of Malnutrition Outcome Measures: A Systematic Review.

Authors:  Līga Savicka; Santa Salaka; Guna Bērziņa
Journal:  J Rehabil Med       Date:  2022-06-20       Impact factor: 3.959

Review 2.  Nutritional Status in Peritoneal Dialysis: Nutritional Guidelines, Adequacy and the Management of Malnutrition.

Authors:  Thomas Kiebalo; Jacqueline Holotka; Ireneusz Habura; Krzysztof Pawlaczyk
Journal:  Nutrients       Date:  2020-06-08       Impact factor: 5.717

3.  Development of a risk prediction model for infection-related mortality in patients undergoing peritoneal dialysis.

Authors:  Hiroaki Tsujikawa; Shigeru Tanaka; Yuta Matsukuma; Hidetoshi Kanai; Kumiko Torisu; Toshiaki Nakano; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

4.  Time-varying serum albumin levels and all-cause mortality in prevalent peritoneal dialysis patients: a 5-year observational study.

Authors:  Na Hao; Ben-Chung Cheng; Hong-Tao Yang; Chien-Hsing Wu; Yang-Yang Lei; Mei-Chen Chao; Pei-Ying Wang; Li-Chueh Kuo; Sin-Hua Moi; Cheng-Hong Yang; Jin-Bor Chen
Journal:  BMC Nephrol       Date:  2019-07-10       Impact factor: 2.388

5.  Subjective Global Nutritional Assessment [SGNA] in Children on Chronic Dialysis- A Prospective Observational Study.

Authors:  Arpana Iyengar; John M R Ashok; Anil Vasudevan
Journal:  Indian J Nephrol       Date:  2022-05-07

6.  Dynamic serum albumin and outcome of peritoneal dialysis patients: A retrospective study in China.

Authors:  Panai Song; Dong Yang; Jine Li; Ning Zhuo; Xiao Fu; Lei Zhang; Hongqing Zhang; Hong Liu; Lin Sun; Yinghong Liu
Journal:  Front Med (Lausanne)       Date:  2022-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.